What is the appropriate treatment plan for a 19-year-old female with a ferritin level of 4 ng/mL?

Treatment Plan for Ferritin of 4 ng/mL in a 19-Year-Old Female

Start oral iron supplementation immediately with 28-50 mg of elemental iron daily, taken on an empty stomach or with vitamin C to enhance absorption, and recheck ferritin and hemoglobin in 8-10 weeks. 1

Diagnostic Confirmation and Baseline Assessment

With a ferritin of 4 ng/mL, this patient has severe iron deficiency—well below the 30 µg/L threshold recommended for females aged >15 years 1. Before initiating treatment, obtain:

• Complete blood count to assess for anemia (hemoglobin <12 g/dL defines IDA in women) 2
• Mean cellular volume (MCV) and mean cellular hemoglobin (MCH) to evaluate microcytosis/hypochromia
• C-reactive protein (CRP) to exclude inflammatory conditions that could falsely elevate ferritin 1

Identify the Underlying Cause

In a 19-year-old female, the most likely etiology is menstrual blood loss, but you must systematically evaluate:

• Menstrual history: Document cycle length, duration, and heaviness (heavy menstrual bleeding is the leading cause in this demographic) 3
• Dietary assessment: Screen for vegetarian/vegan diet, eating disorders, or inadequate dietary iron intake 2, 1
• Gastrointestinal evaluation: Consider celiac disease screening, H. pylori testing, and evaluation for malabsorption if dietary intake is adequate and menstrual losses don't explain the severity 2

First-Line Treatment: Oral Iron

Prescribe ferrous sulfate, ferrous fumarate, or ferrous gluconate containing 28-50 mg of elemental iron daily 1. This moderate dose minimizes gastrointestinal side effects (nausea, constipation, abdominal pain) that cause non-adherence, while still providing adequate repletion 1.

Optimization strategies:

• Take on an empty stomach for maximum absorption, though taking with food is acceptable if GI symptoms are intolerable 2
• Add 500 mg vitamin C to enhance absorption, especially if taken with meals 2
• Avoid calcium supplements and high-fiber foods at the time of iron dosing, as these inhibit absorption 2

Alternative formulations:

If standard ferrous salts are not tolerated, consider ferrous bisglycinate, which demonstrated superior ferritin increases compared to ferrous sulfate in one intervention study 4, though it may be more expensive 2.

When to Consider Intravenous Iron

Reserve IV iron for specific scenarios 1, 5:

• Failure of oral therapy after 8-10 weeks of adequate treatment
• Severe intolerance to multiple oral formulations preventing adherence
• Concomitant conditions requiring urgent correction (though less common in otherwise healthy young women)
• Malabsorption disorders (e.g., celiac disease, inflammatory bowel disease) 2

The 2024 AGA guideline emphasizes that oral iron should be attempted first in premenopausal women 2, and the 2017 Swiss guidelines note IV iron is only necessary in "exceptional cases" for this population 1.

Follow-Up and Monitoring

Recheck hemoglobin, ferritin, and complete blood count at 8-10 weeks 1. Success is defined as:

• Ferritin rising above 30 µg/L (ideally >50 µg/L for sustained stores)
• Hemoglobin normalization if anemia was present
• Symptom improvement (fatigue, exercise intolerance)

Long-term management:

• If ferritin normalizes but the underlying cause persists (e.g., ongoing heavy menstrual bleeding), consider intermittent oral iron supplementation to maintain stores 1
• Repeat ferritin every 6-12 months in patients with recurrent deficiency 1
• Address the root cause: gynecology referral for menstrual management, dietary counseling, or GI evaluation as indicated 2

Critical Pitfalls to Avoid

1. Don't wait for anemia to treat: Even non-anemic iron deficiency (ferritin <30 µg/L with normal hemoglobin) causes fatigue and impaired quality of life, particularly in menstruating adolescents 6. A study of adolescent females showed significant fatigue improvement with iron therapy even when baseline hemoglobin was normal 6.

2. Don't over-supplement: Once ferritin normalizes, continuing daily iron without monitoring can lead to iron overload 1. Target ferritin of 50-100 µg/L is appropriate; levels >200 µg/L are unnecessary and potentially harmful 5.

3. Don't ignore treatment failure: If ferritin doesn't rise after 8-10 weeks of documented adherence, investigate for ongoing blood loss, malabsorption, or consider switching to IV iron 1.

4. Don't overlook inflammatory conditions: If CRP is elevated, ferritin may underestimate iron deficiency; add transferrin saturation (TSAT <20% suggests true iron deficiency) 2, 5.

Quality of Life Considerations

With a ferritin of 4 ng/mL, this patient likely experiences significant fatigue, reduced exercise tolerance, and possibly cognitive impairment 1, 6. Iron is essential not just for hemoglobin but for oxidative metabolism and neurotransmitter synthesis 1. Studies in non-anemic iron-deficient adolescent females demonstrate clinically meaningful fatigue reduction within 6 weeks of IV iron therapy 6, with similar benefits expected from oral therapy if tolerated.

The primary goal is restoring iron stores to improve quality of life and prevent progression to anemia, while simultaneously addressing the underlying cause to prevent recurrence 2, 1.